The development of RNA-based medicines is anticipated to be supported by the biochip-based platform. The biochip and nanoparticle delivery technology aid in setting up an extensive, automated manufacturing process. Additionally, the rapid expansion ofapplications, particularly those for drug development, forced numerous R&D organizations and teams to find a method that was both economical and effective. More than 700 medications were being developed in 2021 to treat about 8,000 uncommon disorders. Before going through clinical trials, medications are tested on biochips. The Viennese University of Technology (TU Wien) created a biochip-based technology in May 2022 that enables the production of tissue beads in exact sizes and the commercialization of those beads and pharmaceuticals through a narrow route.
For More details, watch Video- https://lumen5.com/user/poojasalve/biochips-market-klcyq/